Real-world comparative effectiveness of atezolizumab versus durvalumab for extensive-stage small-cell lung cancer
{{output}}
Background: Both atezolizumab and durvalumab combined with platinum-etoposide have become standard first-line treatments for extensive-stage small-cell lung cancer (ES-SCLC), yet head-to-head real-world comparative data remain sc... ...
